Document is current

Article History

Received: 9 July 2025

Revised: 1 October 2025

Accepted: 17 October 2025

First Online: 23 October 2025

Declarations

:

: Comité de Protection des Personnes Sud-Est V (ref : CPP-08-RESM-01) approved this study.

: Informed consent was obtained from all individual participants included in the study.

: HW reports lecture/consulting fees from Astra Zeneca, Allergopharma, Bioprojet, Boehringer Ingelheim, Chiesi, GSK, Novartis, Inspire, Jazz and ResMed, and research support from ResMed and Novartis. KW has no conflict of interest. AKS has received speaker and travel fees from ResMed. MA has received grant support from ResMed, the ResMed Foundation, Philips Respironics, the Else-Kroehner Fresenisus Foundation, and the Federal Ministry of Education and Research (BMBF), and has received lecture and consulting fees from ResMed, Philips Respironics, Inspire Medical Systems, Zoll Respicardia and Eli Lilly, all outside the submitted work. JLP is supported by the French National Research Agency in the framework of the Investissements d’Avenir program [Grant ANR-15-IDEX-02] and the e-Health and Integrated Care and Trajectories Medicine, and MIAI Artificial Intelligence chairs of excellence from the Grenoble Alpes University Foundation (ANR-19-P3IA-0003). JLP also reports lecture fees or conference travel grants from ResMed, Philips, Jazz Pharmaceuticals, Agiradom, and Bioprojet. PL has no conflict of interest. RH has received speaker or consultancy fees from ResMed, Jazz Pharmaceuticals, Inspire Medical Systems, Bioprojet, Philips, Merck, Nyxoah, Medtronic, Nestlé and Löwenstein. AM is funded by the National Institutes of Health (NIH), reports income related to medical education from Livanova, Jazz Pharmaceuticals, Zoll and Eli Lilly. ResMed provided a philanthropic donation to UC San Diego, but AM has not received personal income from ResMed or medXcloud. PC is funded by the National Health & Medical Research Council (NHMRC) of Australia. He reports having an appointment to an endowed academic Chair at the University of Sydney that was established from ResMed funding, has received research support from ResMed and SomnoMed, and is a consultant to ResMed, SomnoMed, and Sunrise Medical. AVB is an employee of ResMed. EV has no conflict of interest. MRC has no conflict of interest.